Residual risk of human immunodeficiency virus, hepatitis C, and hepatitis B following implementation of sexual risk behavior‐based screening in Canada
Transfusion · 2026-07 · 66 (7) · 1265-1270
DOI: 10.1111/trf.70244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 23.04.2026. Verfasst von Chinchin Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Hepatitis B, HIV Infections, Hepatitis C, Sexual Behavior. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
In 2022, Canadian Blood Services implemented a gender‐neutral sexual behavior‐based screening (SBBS) approach to donor deferral, replacing time‐based criteria targeting gay, bisexual and other men who have sex with men (gbMSM) and female partners of gbMSM. We assessed the impact of this policy change on human immunodeficiency virus (HIV), hepatitis C (HCV), and hepatitis B (HBV) prevalence, incidence, and residual risk. Study Design and Methods We compared prevalence rates among first‐time donors, incidence rates, and residual risk for allogeneic donations made in the 3 years pre‐SBBS implementation and 3 years post‐SBBS implementation.
Results
HIV and HBV prevalence remained steady while HCV prevalence increased among first‐time donors post SBSS‐implementation. Point estimates for incidence rates and residual risks decreased for each marker post‐implementation, but differences were not significant. Residual risks post‐implementation were 1 in 34.7 million for HIV, 1 in 64.1 million for HCV, and 1 in 3.1 million for HBV.
Discussion
Residual risks of infection remain low following the implementation of a gender‐neutral sexual risk behavior‐based approach to donor deferral. This policy change has not negatively impacted the safety of the Canadian blood supply.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.
- Microbiology, Canadian Blood Services, Ottawa, Ontario, Canada.
- Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
- Donation and Policy Studies, Canadian Blood Services, Ottawa, Ontario, Canada.
- Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
ORCID-Profile: Chinchin Wang, Steven J Drews, Mindy Goldman, Sheila F O'Brien
Zitieren
APA
Wang, C., Drews, S. J., Goldman, M., & O'Brien, S. F. (2026). Residual risk of human immunodeficiency virus, hepatitis C, and hepatitis B following implementation of sexual risk behavior‐based screening in Canada. Transfusion, 66(7), 1265-1270. https://doi.org/10.1111/trf.70244
Vancouver
Wang C, Drews SJ, Goldman M, O'Brien SF. Residual risk of human immunodeficiency virus, hepatitis C, and hepatitis B following implementation of sexual risk behavior‐based screening in Canada. Transfusion. 2026;66(7):1265-1270. doi:10.1111/trf.70244
BibTeX
@article{Wang2026,
author = {Wang, Chinchin and Drews, Steven J and Goldman, Mindy and O'Brien, Sheila F},
title = {Residual risk of human immunodeficiency virus, hepatitis C, and hepatitis B following implementation of sexual risk behavior‐based screening in Canada},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {7},
pages = {1265--1270},
doi = {10.1111/trf.70244}
}
EUVIMED